skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Tumors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Abaza, Yasmin ; Zeidan, Amer M

Cells (Basel, Switzerland), 2022-07, Vol.11 (14), p.2249 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
2
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors

Adams, David J. ; Waud, William R. ; Wani, Mansukh C. ; Manikumar, Govindarajan ; Flowers, James L. ; Driscoll, Timothy A. ; Morgan, Lee Roy

Cancer chemotherapy and pharmacology, 2011-04, Vol.67 (4), p.855-865 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
3
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics

Adimora, Ijele J. ; Wilson, Nathaniel R. ; Pemmaraju, Naveen

Cancer, 2022-08, Vol.128 (16), p.3019-3026 [Periódico revisado por pares]

Atlanta: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: a rare entity with challenging diagnosis and management
Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: a rare entity with challenging diagnosis and management
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: a rare entity with challenging diagnosis and management

Agarwal, Ankit ; Amit, Michelle ; Chaffin, Joanna ; Strobel, Amanda

BMJ case reports, 2023-05, Vol.16 (5), p.e254008 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
5
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

Ahenkorah, Stephen ; Cassells, Irwin ; Deroose, Christophe M ; Cardinaels, Thomas ; Burgoyne, Andrew R ; Bormans, Guy ; Ooms, Maarten ; Cleeren, Frederik

Pharmaceutics, 2021-04, Vol.13 (5), p.599 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
6
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells

Ai, Weiyun Z. ; Hou, Jing‐Zhou ; Zeiser, Robert ; Czerwinski, Debra ; Negrin, Robert S. ; Levy, Ronald

International journal of cancer, 2009-01, Vol.124 (1), p.239-244 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
7
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

ALFARO, C ; SUAREZ, N ; GRANDE-PULIDO, E ; MELERO, I ; PEREZ-GRACIA, J. L ; GONZALEZ, A ; SOLANO, S ; ERRO, L ; DUBROT, J ; PALAZON, A ; HERVAS-STUBBS, S ; GURPIDE, A ; LOPEZ-PICAZO, J. M

British journal of cancer, 2009-04, Vol.100 (7), p.1111-1119 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?

Alhamarneh, Osama ; Amarnath, Shoba M. P. ; Stafford, Nicholas D. ; Greenman, John

Head & neck, 2008-02, Vol.30 (2), p.251-261 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications
Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of Tumor Targeting Gold Nanoparticles for Glioblastoma Applications

Allen, Nicholas C. ; Chauhan, Rajat ; Bates, Paula J. ; O’Toole, Martin G.

Nanomaterials (Basel, Switzerland), 2022-11, Vol.12 (21), p.3869 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
10
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

AMADORI, Sergio ; SUCIU, Stefan ; THOMAS, Xavier ; LATAGLIATA, Roberto ; HALKES, Constantijn J. M ; FALZETTI, Franca ; MAGRO, Domenico ; GUIMARAES, José E ; BERNEMAN, Zwi ; SPECCHIA, Giorgina ; KARRASCH, Matthias ; FAZI, Paola ; STASI, Roberto ; VIGNETTI, Marco ; WILLEMZE, Roel ; DE WITTE, Theo ; MARIE, Jean-Pierre ; SALIH, Helmut R ; SELLESLAG, Dominik ; MUUS, Petra ; DE FABRITIIS, Paolo ; VENDITTI, Adriano ; HO, Anthony D ; LÜBBERT, Michael

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4424-4430 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (368)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (377)
  2. Newsletter Articles  (4)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2005  (13)
  2. 2005Até2008  (43)
  3. 2009Até2012  (97)
  4. 2013Até2017  (93)
  5. Após 2017  (136)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.